Hiroki Ikeda
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 20, 2022
Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents.Nobuhiro Hattori, Hiroki Ikeda, Tsunamasa Watanabe
|Nov 24, 2021
Prediction of esophagogastric varices associated with oxaliplatin administration.Yosuke Satta, Ryuta Shigefuku, Tsunamasa Watanabe
|Oct 15, 2019
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.Hidenori Toyoda, Masanori Atsukawa, Tsunamasa Watanabe
|Jul 07, 2019
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.Hiroki Ikeda, Tsunamasa Watanabe, Masanori Atsukawa
|Aug 26, 2018
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.Masanori Atsukawa, Akihito Tsubota, Hidenori Toyoda
Pageof 1
Frequent Collaborators
3 joint publications
Hidenori Toyoda
2 joint publications
Haruki Uojima
2 joint publications
Masanori Atsukawa
2 joint publications
Hiroshi Yasuda
2 joint publications
Tsunamasa Watanabe
1 joint publications
Akito Nozaki
1 joint publications
Joji Tani
1 joint publications
Yoshihiko Tachi
1 joint publications
Atsushi Hiraoka
1 joint publications
Takuya Genda
